| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 12/06/2012 | US20120309833 Novel bexarotene analogs |
| 12/06/2012 | US20120309827 Therapeutic compositions |
| 12/06/2012 | US20120309819 Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents |
| 12/06/2012 | US20120309814 Treatment of pyrroline-5-carboxylate reductase 1 (pycr1) related diseases by inhibition of natural antisense transcript to pycr1 |
| 12/06/2012 | US20120309811 P-glycoprotein-specific non-competitive peptide and peptidomimetic modulators |
| 12/06/2012 | US20120309808 Compositions and methods for epigenetic modification of nucleic acid sequences |
| 12/06/2012 | US20120309800 Metalloenzyme inhibitor compounds |
| 12/06/2012 | US20120309799 Biguanide derivative, preparation method thereof, and pharmaceutical composition containing same as an active ingredient |
| 12/06/2012 | US20120309798 Tumour Treatment Agents and Method |
| 12/06/2012 | US20120309797 Pyridyl cyanoguanidine derivatives |
| 12/06/2012 | US20120309795 Heterocyclic inhibitors of necroptosis |
| 12/06/2012 | US20120309794 Compounds inhibitors of enzyme lactate dehydrogenase (ldh) and pharmaceutical compositions containing these compounds |
| 12/06/2012 | US20120309791 Novel compound for the treatment of diseases associated with amyloid or amyloid-like proteins |
| 12/06/2012 | US20120309783 Kinase inhibitors with improved cyp safety profile |
| 12/06/2012 | US20120309781 TETRAHYDRO-beta-CARBOLINE DERIVATIVES, SYNTHESIS AND USE THEREOF |
| 12/06/2012 | US20120309775 4-methylpyridopyrimidinone compounds |
| 12/06/2012 | US20120309774 Selective antagonists of a2a adenosine receptors |
| 12/06/2012 | US20120309773 Heterocyclic compounds as janus kinase inhibitors |
| 12/06/2012 | US20120309768 Novel tubulin polymerisation inhibitors |
| 12/06/2012 | US20120309767 Process for the preparation of alpha form of imatinib mesylate |
| 12/06/2012 | US20120309766 Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors |
| 12/06/2012 | US20120309765 5-anilinoimidazopyridines and methods of use |
| 12/06/2012 | US20120309759 Screening Method and Compounds for Modulating Telomerase Activity |
| 12/06/2012 | US20120309750 5-membered heterocycle derivatives and manufacturing process thereof |
| 12/06/2012 | US20120309748 Conjugated psychotropic drugs and uses thereof |
| 12/06/2012 | US20120309747 Protein kinase inhibitors |
| 12/06/2012 | US20120309746 Triazolopyridine compounds |
| 12/06/2012 | US20120309744 Dosing regimens and methods for treating or preventing hepatocellular carcinoma |
| 12/06/2012 | US20120309743 Thiolactams and uses thereof |
| 12/06/2012 | US20120309741 Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors |
| 12/06/2012 | US20120309739 Akt / pkb inhibitors |
| 12/06/2012 | US20120309736 Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| 12/06/2012 | US20120309734 Combretastatin derivatives and uses therefor |
| 12/06/2012 | US20120309732 METHOD FOR INHIBITION OF TUMOR CELL GROWTH USING (22R)-5alpha-LANOSTA-8,24-DIEN-3Beta,15alpha,21-TRIOL |
| 12/06/2012 | US20120309730 Oxysterols that activate liver x receptor signaling and inhibit hedgehog signaling |
| 12/06/2012 | US20120309721 Method for providing neuroprotection |
| 12/06/2012 | US20120309719 (22e)-2-methylene-26,27-cyclo-22-dehydro-1alpha-hydroxy-19-norvitamin d3 derivatives |
| 12/06/2012 | US20120309717 Compounds, methods and pharmaceutical compositions for inhibiting parp |
| 12/06/2012 | US20120309713 N-Cyclopropyl-(20R)-2-Methylene-19,26,27-Trinor-25-Aza-Vitamin D Analogs and Their Uses |
| 12/06/2012 | US20120309711 Modified pectins, compositions and methods related thereto |
| 12/06/2012 | US20120309706 Combined treatment of pancreatic cancer with gemcitabine and masitinib |
| 12/06/2012 | US20120309704 Compositions for treatment of chemoresistant and/or potentially chemoresistant leukaemias |
| 12/06/2012 | US20120309702 Dynamic inhibitors of heat shock protein 90 |
| 12/06/2012 | US20120309699 Compounds having anti-inflammatory activity |
| 12/06/2012 | US20120309697 Methods of diagnosing and prognosing colonic polyps |
| 12/06/2012 | US20120309696 Acth antagonist peptides |
| 12/06/2012 | US20120309692 Activation of Peptide Prodrugs by hK2 |
| 12/06/2012 | US20120309691 Tumor targeted delivery of immunomodulators by nanopolymers |
| 12/06/2012 | US20120309690 Prostaglandin-f2 alpha receptor modulators and uses thereof |
| 12/06/2012 | US20120309682 Suppression of cancer metastasis |
| 12/06/2012 | US20120309674 Pseudodipeptides as mmp inhibitors |
| 12/06/2012 | US20120309628 Bioactive agent delivery particles |
| 12/06/2012 | US20120309086 Methods and use of inducing apoptosis in cancer cells |
| 12/06/2012 | US20120308663 Lipid nanocapsules, method for preparing same and use thereof as a drug |
| 12/06/2012 | US20120308659 Pellet formulation for the treatment of the intenstinal tract |
| 12/06/2012 | US20120308657 Magnetic nanostructures as theranostic agents |
| 12/06/2012 | US20120308651 Salts of benzimidazolyl pyridyl ethers and formulations thereof |
| 12/06/2012 | US20120308647 Use of mir-30e to treat vascular lesions |
| 12/06/2012 | US20120308646 Tetracyclic anthraquinones possessing anti-cancer properties |
| 12/06/2012 | US20120308645 Compositions and methods for sirna inhibition of hif-1 alpha |
| 12/06/2012 | US20120308644 Compositions for mucosal delivery of agents |
| 12/06/2012 | US20120308640 Amphiphilic janus-dendrimers |
| 12/06/2012 | US20120308618 Ic31 nanoparticles |
| 12/06/2012 | US20120308616 Submicro emulsion of paclitaxel using steroid complex as intermediate carrier |
| 12/06/2012 | US20120308612 Compositions and methods for preparation of poorly water soluble drugs with increased stability |
| 12/06/2012 | US20120308608 Interferon-inducing compounds and uses thereof |
| 12/06/2012 | US20120308607 Production and use of human cd124- and cd-116-positive tumor cell lines in the production of allogenic or semi-allogenic immunotherapy agents |
| 12/06/2012 | US20120308605 Pharmaceutical Composition of Killed Cells with Substantially Retained Immunogenicity |
| 12/06/2012 | US20120308601 Methods and materials for treating cancer |
| 12/06/2012 | US20120308591 Tmem22 peptides and vaccines including the same |
| 12/06/2012 | US20120308590 Imp-3 oligopeptides and vaccines including the same |
| 12/06/2012 | US20120308589 Sinomenine derivatives, synthetic methods and uses thereof |
| 12/06/2012 | US20120308586 Composition based on extra virgin olive oils |
| 12/06/2012 | US20120308583 Use of gcc ligands |
| 12/06/2012 | US20120308582 Molecules and methods for modulating tmem16a activities |
| 12/06/2012 | US20120308581 Compositions and methods for detecting tlr3 |
| 12/06/2012 | US20120308576 Monoclonal and oligoclonal anti-egfr antibodies for use in the treatment of tumors expressing predominantly high affinity egfr ligands or tumors expressing predominantly low affinity egfr ligands |
| 12/06/2012 | US20120308574 Human monoclonal antibody that specifically binds to vcam-1 and a composition for treating an inflammatory disease or a cancer comprising the same |
| 12/06/2012 | US20120308573 Anti-IL-23 Antibodies, Compositions, Methods and Uses |
| 12/06/2012 | US20120308571 Anti-podoplanin antibody, and pharmaceutical composition containing anti-podoplanin antibody |
| 12/06/2012 | US20120308569 Gene products differentially expressed in cancerous cells |
| 12/06/2012 | US20120308568 Pharmaceutical composition for inhibiting abnormal proliferation of cells |
| 12/06/2012 | US20120308566 Use of il-17 receptor a antigen binding proteins |
| 12/06/2012 | US20120308565 Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof |
| 12/06/2012 | US20120308563 Regulatory b cells (tbregs) and their use |
| 12/06/2012 | US20120308562 Methods of treating mesothelioma with a pi3k inhibitor compound |
| 12/06/2012 | US20120308560 Antineoplastic Combinations with mTOR Inhibitor, Trastuzumab and/or HKI-272 |
| 12/06/2012 | US20120308558 Methods of Using Antibodies That Bind The Glutamate Ligand Binding Region of Notch1 |
| 12/06/2012 | US20120308548 Methionine gamma lyase-2-aminobutyrate deaminase (megl-2abd) and therapeutic uses thereof |
| 12/06/2012 | US20120308521 Compositions and Methods for Treatment of Cancer Using Tissue-Specific Oncolytic Adenoviruses |
| 12/06/2012 | US20120308520 Crystal of recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof |
| 12/06/2012 | US20120308517 Compositions for the treatment of infectious and tumoural diseases |
| 12/06/2012 | US20120308516 Use of metallocene compounds for cancer treatment |
| 12/06/2012 | US20120308515 Use of gilz protein expressed in dendritic cells to modulate an antigen-specific immune response |
| 12/06/2012 | US20120308484 Clonal strains of attenuated vaccinia viruses and methods of use thereof |
| 12/06/2012 | US20120308480 Humanized antibodies against tl1a |
| 12/06/2012 | US20120308479 Brain Endothelial Cell Expression Patterns |
| 12/06/2012 | US20120308478 Antibodies specific for claudin 6 (cldn6) |
| 12/06/2012 | US20120308477 Brief radioimmunotherapy |
| 12/06/2012 | DE102006053594C5 Verfahren zur Reinigung von Letrozol A process for purifying letrozole |